ePROMS-MEL project – Patient reported outcomes Stage III
Investigating including electronic Patient Reported Outcome Measures into routine care for Stage III melanoma patients.
Investigating including electronic Patient Reported Outcome Measures into routine care for Stage III melanoma patients.
The Garrow family honour their dearly loved family member Ben with the Ben Garrow PhD Scholarship.
The Retreat shared highlights from MIA-led research activities. Despite COVID research has continued unabated.
Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine.
Successful trial of a new immunotherapy drug which offers a third, and less toxic, option for the treatment of advanced melanoma.
As leaders in melanoma field, researchers from MIA shared their knowledge at 10th World Congress of Melanoma.
New research has shed light on why advanced melanoma that has spread to the liver is particularly resistant to immunotherapy.
The discovery of dramatic genetic changes may be key to developing new melanoma treatments.
MIA Co-Medical Director, Professor Georgina Long, who has been recognised in the 2020 Queen’s Birthday Honours List.
The end of the year is fast approaching and it’s time to thank our amazing community fundraisers.